Trump Executive Order Tracker | Akin Public Policy and Lobbying

Protecting Children from Chemical and Surgical Mutilation (Trump EO Tracker)

January 24, 2025

Reading Time : 2 min
Trump Executive Order Tracker | Akin Public Policy and Lobbying

Key Updates

Summary

The Executive Order announces that the United States "will not fund, sponsor, promote, assist, or support the so-called ‘transition’ of a child from one sex to another and will rigorously enforce all laws that prohibit or limit these procedures. The order directs all agencies to rescind and amend all policies that rely on guidance from the World Professional Association for Transgender Health (WPATH). The order makes additional directives to the heads of executive departments and agencies, such as the Secretary of HHS, to take immediate actions to prevent the “chemical and surgical mutilation of children.” The order also directs the Director of the Office of Personnel Management to include provisions in the Federal Employee Health Benefits and Postal Service Health Benefits programs excluding coverage for pediatric transgender surgeries or hormone treatments.

Deadline as stated in original EO: Within 90 days, the Secretary of HHS shall publish a review of existing literature on best practices for promoting the health of children with gender dysphoria “or other identity-based confusion.” Within 60 days, the heads of agencies identified in the EO shall submit a single report to the Assistant to the President for Domestic Policy detailing implementation progress and a timeline for future action. 

Legal Challenges

Case Name PLGAG Inc. et al. v. Donald J. Trump et al., Case No. 1:25-cv-00337
Date Complaint Filed February 4, 2025 (amended complaint)
Venue

United States District Court for the District of Maryland

Summary

Plaintiffs are seeking to enjoin Defendants (President Trump and various agencies and officials) from implementing or enforcing Section 3(g) of E.O. 14168 and E.O. 14187 and declare these provisions unconstitutional and unlawful. They argue that these executive orders are in excess of presidential authority, conflict with existing statutes, violate the Equal Protection Clause of the Fifth Amendment, violate Substantive Due Process under the Fifth Amendment, and violate the Plaintiff’s freedom of speech under the First Amendment.

Related Cases

Additional Documentation

Share This Insight

Related Content

Trump Executive Order Tracker

The significant number of executive orders published by the Trump Administration cut across dozens of industries and areas of law. This searchable tool breaks down the orders and their impacts on specific industries and with in-depth analysis of specific orders.

Previous Entries

Trump Executive Order Tracker

December 19, 2025

Sets a strategy for U.S. leadership in 6G technology, emphasizing its importance for national security, AI, robotics, and resilient communications. It directs the Commerce Department’s National Telecommunications and Information Administration to “immediately begin the process of identifying” the 7.125-7.4 GHz band for “reallocation for full-powered commercial licensed use” and study how to reallocate federal systems in the band “to other frequencies” while ensuring that critical defense and electric grid missions remain unaffected. Authorizes studies to explore reallocating portions of the 2.69–2.9 GHz and 4.4–4.94 GHz bands. These efforts aim to accelerate spectrum availability for next-generation networks without compromising existing federal operations. Tasks the State Department and other agencies to lead diplomatic efforts with the ITU to advance U.S. objectives on global spectrum policy.

...

Read More

Trump Executive Order Tracker

December 18, 2025

This order directs the Attorney General to complete the rulemaking process to reschedule marijuana to Schedule III of the Controlled Substances Act. Schedule III drugs are classified as having a potential for abuse less than those drugs in Schedules I and II, a currently accepted medical use in treatment in the United States, and a potential for moderate or low physical dependence or high psychological dependence in the event of drug abuse.

...

Read More

Trump Executive Order Tracker

December 16, 2025

Suspends entry for foreign nationals of additional countries of concern from those previously restricted under Proclamation 10949, as determined by the Secretary of State, the Secretary of Homeland Security, the Attorney General, and the Director of National Intelligence. Additional countries include full suspension of entry for Burkina Faso, Laos, Mali, Niger, Sierra Leone, South Sudan, Syria, Palestinian Authority Documents, and partial suspension of entry for Angola, Antigua and Barbuda, Benin, Cote d ‘Ivoire, Dominica, Gabon, the Gambia, Malawi, Mauritania, Nigeria, Senegal, Tanzania, Tonga, Turkmenistan, Zambia, and Zimbabwe.

...

Read More

Trump Executive Order Tracker

December 15, 2025

Designates illicit fentanyl and its core precursor chemicals as Weapons of Mass Destruction (WMD) and directs the use of national security, criminal, sanctions, intelligence, and military-support authorities to combat fentanyl trafficking. Expands enforcement tools against cartels and foreign terrorist organizations involved in fentanyl production and distributions.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.